Arrowstreet Capital, Limited Partnership G1 Therapeutics, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

  • $120 Billion
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$17.58 - $32.59 $969,449 - $1.8 Million
-55,145 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$10.99 - $20.4 $606,043 - $1.12 Million
55,145 New
55,145 $992,000
Q3 2020

Nov 12, 2020
SELL
$11.55 - $23.75 $408,870 - $840,750
-35,400 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$9.57 - $24.37 $338,778 - $862,698
35,400 New
35,400 $859,000

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email